Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Neurology Minute · American Academy of Neurology
August 20, 20252m 10s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society's 67th Annual Scientific Meeting in June 2025.
Show reference:
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957